Literature DB >> 7599925

Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors.

V Sexl1, G Mancusi, S Baumgartner-Parzer, W Schütz, M Freissmuth.   

Abstract

1. Adenosine is known to stimulate capillary outgrowth and endothelial cell proliferation, but the underlying mechanism has not been identified. In order to identify the receptor subtype involved, the effects of adenosine receptor agonists and antagonists on human umbilical vein endothelial cell (HUVEC) proliferation were investigated. 2. Raising intracellular adenosine levels by use of the adenosine transport inhibitor, 4-nitrobenzylthioinosine (NBMPR) did not affect cell growth. This observation suggests that stimulation of an extracellular adenosine receptor generates the mitogenic signal. 3. In the presence of adenosine deaminase (ADA), which was used to remove adenosine present in the culture medium, the adenosine receptor agonists N-ethylcarboxamidoadenosine (NECA, non-selective) and CGS21680 (A2A-receptor-selective) stimulated [3H]-thymidine incorporation with a half-maximum effect at about 10 nM, while N6-cyclopentyladenosine (CPA, A1-selective) was about 100 fold less potent. The adenosine receptor antagonist, xanthine amine congener (XAC) produced a concentration-dependent decrease in endothelial cell proliferation with a half-maximum effect at about 10 nM. Hence, stimulation of an endothelial A2A-adenosine receptor seems responsible for the mitogenic signal. 4. In the presence of ADA, isoprenaline is also able to stimulate [3H]-thymidine incorporation with a half maximal effect of about 3 nM, an effect, which is reversed by the highly beta 2-selective antagonist, ICI 118,551. In the absence of ADA, isoprenaline exerts only a minor stimulatory effect. Combination of A2A adenosine and beta 2-adrenoceptor agonists did not further enhance [3H]-thymidine incorporation when compared to the sole addition of each agonist. We therefore conclude that both receptors stimulate endothelial cell proliferation via a common signal transduction pathway. 5. Both receptors are coupled to stimulation of adenylyl cyclase via the stimulatory G protein G8.However, direct activation of downstream effectors in the cyclic AMP-signalling cascade (G8 with cholera toxin, adenylyl cyclase with forskolin, protein kinase A with 8Br-cyclic AMP) not only failed to mimic the action of receptor-activation, but even reduced cell proliferation.6. Similarly, pertussis toxin-treatment which inactivated the Gi 2 protein present in HUVEC and thus inhibited cell proliferation per se, did not impair the ability of A2A-receptor agonists to stimulate cell proliferation. This suggests that the A2A-adenosine and beta2-adrenoceptor-mediated stimulation of endothelial cell proliferation occurs via a mechanism that is independent of G8 and Gi.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599925      PMCID: PMC1510404          DOI: 10.1111/j.1476-5381.1995.tb14942.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins.

Authors:  J Bauer; M Margolis; C Schreiner; C J Edgell; J Azizkhan; E Lazarowski; R L Juliano
Journal:  J Cell Physiol       Date:  1992-12       Impact factor: 6.384

2.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

3.  Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels.

Authors:  W Schütz; G Steurer; E Tuisl
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

4.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

5.  Identification of the predominant substrate for ADP-ribosylation by islet activating protein.

Authors:  G M Bokoch; T Katada; J K Northup; E L Hewlett; A G Gilman
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

6.  Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3',5'-cyclic adenosine monophosphate on cell replication in human T lymphocytes.

Authors:  B S Skålhegg; B F Landmark; S O Døskeland; V Hansson; T Lea; T Jahnsen
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

7.  Molecular cloning and expression of an adenosine A2b receptor from human brain.

Authors:  K D Pierce; T J Furlong; L A Selbie; J Shine
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

8.  Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.

Authors:  J E Souness; G A Hassall; D P Parrott
Journal:  Biochem Pharmacol       Date:  1992-09-01       Impact factor: 5.858

9.  The regulatory component of adenylate cyclase. Purification and properties.

Authors:  P C Sternweis; J K Northup; M D Smigel; A G Gilman
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

Review 10.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

View more
  17 in total

Review 1.  The A(2A)-adenosine receptor: a GPCR with unique features?

Authors:  J Zezula; M Freissmuth
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

2.  Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development.

Authors:  Majid Katebi; Mansooreh Soleimani; Bruce N Cronstein
Journal:  J Leukoc Biol       Date:  2008-12-12       Impact factor: 4.962

Review 3.  Adenosine receptors in wound healing, fibrosis and angiogenesis.

Authors:  Igor Feoktistov; Italo Biaggioni; Bruce N Cronstein
Journal:  Handb Exp Pharmacol       Date:  2009

4.  High-glucose incubation of human umbilical-vein endothelial cells does not alter expression and function either of G-protein alpha-subunits or of endothelial NO synthase.

Authors:  G Mancusi; C Hutter; S Baumgartner-Parzer; K Schmidt; W Schütz; V Sexl
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

5.  [MUV Researcher of the Month, October 2014].

Authors:  Christian Bergmayr
Journal:  Wien Klin Wochenschr       Date:  2014-10       Impact factor: 1.704

6.  A novel role for an endothelial adrenergic receptor system in mediating catecholestradiol-induced proliferation of uterine artery endothelial cells.

Authors:  Sheikh O Jobe; Sean N Fling; Jayanth Ramadoss; Ronald R Magness
Journal:  Hypertension       Date:  2011-09-26       Impact factor: 10.190

7.  Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cells.

Authors:  Luigia Di Francesco; Melania Dovizio; Annalisa Trenti; Emanuela Marcantoni; Ashleigh Moore; Peadar O'Gaora; Cathal McCarthy; Stefania Tacconelli; Annalisa Bruno; Sara Alberti; Salvatore Gizzo; Giovanni Battista Nardelli; Genny Orso; Orina Belton; Lucia Trevisi; Dan A Dixon; Paola Patrignani
Journal:  Br J Pharmacol       Date:  2015-08-03       Impact factor: 8.739

8.  The role of adenosine receptors in the action of theophylline on human peripheral blood mononuclear cells from healthy and asthmatic subjects.

Authors:  L J Landells; M W Jensen; L M Orr; D Spina; B J O'Connor; C P Page
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

9.  Effects of isoprenaline on endothelial connexins and angiogenesis in a human endothelial cell culture system.

Authors:  Stefan Dhein; Christiane Gaertner; Christian Georgieff; Aida Salameh; Franziska Schlegel; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-31       Impact factor: 3.000

10.  Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors.

Authors:  M Carmen Montesinos; Avani Desai; Jiang-Fan Chen; Herman Yee; Michael A Schwarzschild; J Stephen Fink; Bruce N Cronstein
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.